已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Insights from the Altshock-2 registry on intra-aortic balloon pump use in acute decompensated heart failure complicated by cardiogenic shock

作者
Giacomo Ruzzenenti,Chiara Colombo,G Maj,Simone Frea,C Sorini-Dini,Marco Marini,Martina Briani,Maurizio Bertaina,Luciano Potena,Gaetano Maria De Ferrari,Nuccia Morici,Federico Pappalardo,Guido Tavazzi,Alice Sacco
出处
期刊:European heart journal. Acute cardiovascular care [Oxford University Press]
卷期号:14 (Supplement_1)
标识
DOI:10.1093/ehjacc/zuaf044.149
摘要

Abstract Introduction and purpose intra-aortic balloon pump (IABP) is an ECG-gated, volume-displacement device that, while only modestly increasing cardiac output, significantly reduces left ventricle (LV) afterload. Acute decompensated heart failure (ADHF) cardiogenic shock (CS) is mechanistically characterized by a ventricular afterload mismatch. Cardiac output (CO) becomes highly sensitive to afterload changes and can improve significantly with its reduction by IABP. This study aimed to evaluate the outcomes of patients (pts) with ADHF-CS treated with IABP. Methods pts presenting with CS were consecutively enrolled between March 2020 and November 2023 in a multicenter cohort prospective study. We focused on ADHF-CS. Specific comparing tests were used for continuous variables, depending on their distribution, and for categorical variables. Kaplan–Meier and log-rank test were used for survival analysis. Multivariate logistic regression identified predictors of 60-day mortality. Results pts were categorized according to IABP use. A total of 189 ADHF-CS pts were analysed: 81 received IABP, 108 were treated with inotropes or other mechanical circulatory support (MCS) options, including Impella and ECMO. Baseline characteristics were similar between groups, except for age, kidney disease, left ventricular ejection fraction (LVEF) and heart transplant (HT) listing. The median time from Cardiac Intensive Care Unit (CICU) admission to IABP placement was 2 (IQR: 1.0-11.5) days, with a support duration of 168 hours (IQR: 94-438). Although not statistically significant, the complication rate was lower in the IABP group. Vasoactive agents were used in 95% of pts, with epinephrine being the most common in IABP group. Use of mechanical ventilation, renal replacement therapy, enteral nutrition and sedative drugs were similar. HT rate was higher in the IABP group, in-hospital mortality didn’t differ. IABP pts showed significantly better survival at 60 days, 6 months, and 1 year. Although pts in lower SCAI classes (A, B, and C) had better survival than those in advanced stages (D and E), there was a remarkable difference in the latter SCAI stages (D-E) amongst those not receiving and those receiving IABP (OR 6.5; CI: 1.6 - 26.4, p = 0.009). On univariate analysis, variables associated with 60-day mortality included age, atrial fibrillation, kidney disease, known cardiomyopathy, noradrenaline use, in-hospital cardiac arrest, SOFA and SAPS scores, and SCAI class. Although not statistically significant, IABP use showed a protective trend (p = 0.056). On multivariate analysis, mortality was linked to kidney disease, SCAI class, significant tricuspid regurgitation and in-hospital cardiac arrest. Conclusion IABP demonstrates potential as an effective support intervention in managing ADHF-CS including pts within advanced SCAI class stages. Further investigation is recommended to clarify its benefits in advanced cases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
TX完成签到,获得积分10
4秒前
4秒前
5秒前
朴实无招完成签到,获得积分10
7秒前
TTTTT完成签到 ,获得积分10
7秒前
李爱国的应助被DW采纳,获得10
8秒前
9秒前
Leung完成签到,获得积分10
9秒前
dd完成签到 ,获得积分10
9秒前
饱饱发布了新的文献求助10
10秒前
jcz的应助被ernest采纳,获得150
10秒前
11秒前
URB7完成签到,获得积分10
11秒前
刻苦乐天完成签到,获得积分10
12秒前
顺心惜文完成签到 ,获得积分10
12秒前
13秒前
14秒前
milk完成签到 ,获得积分10
16秒前
传奇3的应助被数智采纳,获得10
17秒前
Danny完成签到,获得积分10
17秒前
17秒前
19秒前
lujibaqi发布了新的文献求助10
19秒前
忘忧草完成签到 ,获得积分10
19秒前
Anserbe完成签到 ,获得积分10
19秒前
20秒前
It完成签到 ,获得积分10
20秒前
GingerF的应助被DW采纳,获得50
20秒前
sss完成签到,获得积分20
24秒前
24秒前
夏目完成签到,获得积分10
25秒前
谦让夏山完成签到 ,获得积分10
25秒前
土豆豆完成签到 ,获得积分10
26秒前
兴奋枫完成签到,获得积分10
26秒前
gmy发布了新的文献求助10
26秒前
小正完成签到,获得积分10
27秒前
yueqi完成签到,获得积分10
28秒前
一口一完成签到 ,获得积分10
29秒前
yingying完成签到 ,获得积分10
30秒前
WYT发布了新的文献求助10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184828
求助须知:如何正确求助?哪些是违规求助? 9573791
关于积分的说明 21833034
捐赠科研通 7782127
什么是DOI,文献DOI怎么找? 3434405
关于科研通互助平台的介绍 2558545
邀请新用户注册赠送积分活动 2481067